Clinical Trial Update: A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics [Phase 2]

View source ↗

Summary

Phase 2 trial update of IBI112 in Chinese patients with psoriasis who were previously treated with biologics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• IBI112

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED